NO20004920L - Anvendelse av proteaseinhibitorer for behandling av hudsår - Google Patents

Anvendelse av proteaseinhibitorer for behandling av hudsår

Info

Publication number
NO20004920L
NO20004920L NO20004920A NO20004920A NO20004920L NO 20004920 L NO20004920 L NO 20004920L NO 20004920 A NO20004920 A NO 20004920A NO 20004920 A NO20004920 A NO 20004920A NO 20004920 L NO20004920 L NO 20004920L
Authority
NO
Norway
Prior art keywords
protease inhibitors
treatment
skin ulcers
inhibitors
paj
Prior art date
Application number
NO20004920A
Other languages
English (en)
Other versions
NO20004920D0 (no
Inventor
Clive L Bunn
John Andrews
Phillip Sharp
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of NO20004920D0 publication Critical patent/NO20004920D0/no
Publication of NO20004920L publication Critical patent/NO20004920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Heling av kroniske sår, slik som leggsår, akselereres ved topisk administrering av en serinproteaseinhibitor, slik som PAJ-2. Sårheling fremmes også ved anvendelse av kombinasjoner av proteinaseinhibitorer, slik som PAJ-2 med andre serinproteaseinhibitorer og/eller med proteaseinhibitorer, slik som henholdsvis inhibitorer av metallproteinaser, sure proteaser og tiolproteaser.
NO20004920A 1998-04-01 2000-09-29 Anvendelse av proteaseinhibitorer for behandling av hudsår NO20004920L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8031598P 1998-04-01 1998-04-01
US8468298P 1998-05-07 1998-05-07
PCT/IB1998/001917 WO1999049887A1 (en) 1998-04-01 1998-11-13 Use of protease inhibitors for treating skin wounds

Publications (2)

Publication Number Publication Date
NO20004920D0 NO20004920D0 (no) 2000-09-29
NO20004920L true NO20004920L (no) 2000-11-30

Family

ID=26763356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004920A NO20004920L (no) 1998-04-01 2000-09-29 Anvendelse av proteaseinhibitorer for behandling av hudsår

Country Status (10)

Country Link
US (1) US6344189B1 (no)
EP (1) EP1071448A4 (no)
JP (1) JP2002526382A (no)
KR (1) KR20010042402A (no)
CN (1) CN1299286A (no)
AU (1) AU1170899A (no)
CA (1) CA2326438A1 (no)
IL (1) IL138594A0 (no)
NO (1) NO20004920L (no)
WO (1) WO1999049887A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
AU2003286258B2 (en) * 2002-11-20 2006-12-21 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
US7217690B2 (en) * 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
WO2009045543A1 (en) 2007-10-04 2009-04-09 The Regents Of The University Of California Treatment of conditions related to shock
PL2205623T3 (pl) * 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
US8841258B2 (en) * 2009-09-28 2014-09-23 The Regents Of The University Of California Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
JP2013538858A (ja) 2010-10-02 2013-10-17 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 腸機能不全の最小化
JP6948741B1 (ja) * 2021-03-30 2021-10-13 株式会社セテカ 細胞賦活化剤、及びそれを含む皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202118A (en) 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
DE3829523A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression
DK0446315T3 (da) * 1989-09-05 1998-01-05 Biotech Australia Pty Ltd Fremgangsmåde til fremstilling af PAI-2
AU625018B2 (en) 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
EP0451130A3 (en) * 1990-04-05 1992-08-05 Baltimore Biotech, Inc. Use of amiloride and other pyrazine derivatives for preventing or treating ocular neovascularization
ATE146970T1 (de) * 1990-10-16 1997-01-15 John Lezdey Behandlung von entzündungen
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
DE4214999C2 (de) 1992-05-06 1994-07-14 Behringwerke Ag Reinigung von Plasminogen-Aktivator-Inhibitor 2 durch Immunaffinitätschromatographie
US5679350A (en) 1992-05-28 1997-10-21 The University Of Toledo Method of delivery of a medicament to a cancer cell using a pathway of plasminogen activator material
WO1994005322A1 (en) * 1992-09-04 1994-03-17 Summit Technology, Inc. A plasmin activity reducing agent for treating a superficial corneal ablation wound and related screening method
JPH0782169A (ja) 1993-09-13 1995-03-28 Toray Ind Inc 創傷治療剤
US5599788A (en) 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US5693332C1 (en) 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5919436A (en) * 1997-09-25 1999-07-06 The Board Of Regents Of The University Of Oklahoma Method of lightening skin

Also Published As

Publication number Publication date
US6344189B1 (en) 2002-02-05
CN1299286A (zh) 2001-06-13
CA2326438A1 (en) 1999-10-07
JP2002526382A (ja) 2002-08-20
EP1071448A4 (en) 2003-07-23
WO1999049887A1 (en) 1999-10-07
EP1071448A1 (en) 2001-01-31
NO20004920D0 (no) 2000-09-29
AU1170899A (en) 1999-10-18
IL138594A0 (en) 2001-10-31
KR20010042402A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
IL222773A0 (en) Biaryl compounds as serine protease inhibitors pharmaceutical compostions, uses, in vitro methods and devices comprising such compounds
MXPA03009130A (es) Compuestos de biarilo que funcionan como inhibidores de proteasa serina.
ATE307111T1 (de) Serinprotease-inhibitoren
WO2003018748A3 (en) Anti-cancer and wound healing compounds
TR200103493T2 (tr) Metaloproteaz önleyicileri
NO20060416L (no) Ny anvendelse I
ATE337785T1 (de) Tiotropiumsalze zur behandlung von entzündlichen erkrankungen
NO983688L (no) Serin-protease-inhibitorer
TR199902692T2 (xx) Serin proteaz inhibit�rleri.
NO20004920L (no) Anvendelse av proteaseinhibitorer for behandling av hudsår
ES2193615T3 (es) .nhibidor de la angiogenesis.
ITPD20050207A1 (it) Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
NZ507050A (en) Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
CY1111905T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα εναν επιλεκτικο αναστολεα της αμινοπεπτιδασης α, ειδικα τον ec33, για τη μειωση της αρτηριακης πιεσεως
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
ATE330601T1 (de) Sulfonamide als matrix-metalloproteinase inhibitoren
GB0025670D0 (en) Preparation for the relief of inflammatory disease
TR199801704T2 (xx) Serin proteaz inhibit�rleri.
DK0782441T3 (da) Farmaceutisk kontrol af inflammation
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
BR0009186A (pt) Sais de ácidos asiático e madecássico adequados para preparação de composições farmacêuticas e cosméticas
ATE92960T1 (de) Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.
AR021241A1 (es) Inhibidores de proteasas
NO20010569L (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application